Variable | Favorable outcome (n = 178) | Unfavorable outcome (n = 78) | P |
---|---|---|---|
Age (years) | 65.3 ± 11.0 | 69.9 ± 10.2 | 0.002 |
Male, n (%) | 110 (61.8) | 45 (57.7) | 0.536 |
Hypertension, n (%) | 141 (79.2) | 66 (84.6) | 0.312 |
Diabetes, n (%) | 78 (43.8) | 33 (42.3) | 0.822 |
Atrial fibrillation, n (%) | 4 (2.2) | 4 (5.1) | 0.223 |
Stroke history, n (%) | 36 (20.2) | 20 (25.6) | 0.335 |
Smoker, n (%) | 53 (29.8) | 19 (24.4) | 0.375 |
Alcohol user, n (%) | 32 (18.0) | 11 (14.1) | 0.445 |
Etiological subtype, n (%) | |||
LAOD | 39 (21.9) | 20 (25.6) | 0.903 |
CE | 6 (3.4) | 3 (3.8) | |
BABD | 72 (40.4) | 33 (42.3) | |
SAD | 35 (19.7) | 13 (16.7) | |
OE | 26 (14.6) | 9 (11.5) | |
NIHSS score | 4 (3–6) | 8 (7–10) | < 0.001 |
Admission to blood sampling time (h) | 16.4 (14.3–20.8) | 18.0 (14.5–21.3) | 0.472 |
SBP (mmHg) | 151.9 ± 20.1 | 152.6 ± 21.4 | 0.796 |
DBP (mmHg) | 87.9 ± 11.6 | 89.5 ± 10.1 | 0.286 |
Neutrophils (109/L) | 4.1 ± 1.3 | 5.4 ± 2.0 | < 0.001 |
Lymphocytes (109/L) | 1.8 ± 0.5 | 1.5 ± 0.5 | < 0.001 |
Platelets (109/L) | 170.8 ± 45.9 | 186.0 ± 49.9 | 0.019 |
NLR | 2.2 (1.7–2.9) | 3.4 (2.6–4.7) | < 0.001 |
PLR | 94.2 (78.9–115.3) | 125.5 (96.6–143.0) | < 0.001 |
NLR (n,%) | < 0.001 | ||
Low tertile | 74 (41.6) | 11 (14.1) | |
Middle tertile | 71 (39.9) | 16 (20.5) | |
High tertile | 33 (18.5) | 51 (65.4) | |
PLR (n,%) | < 0.001 | ||
Low tertile | 72 (40.4) | 13 (16.7) | |
Middle tertile | 64 (36.0) | 22 (28.2) | |
High tertile | 42 (23.6) | 43 (55.1) | |
FBG (mmol/L) | 5.6 (4.8–7.3) | 5.8 (5.0–8.0) | 0.078 |
TG (mmol/L) | 1.8 (1.3–2.5) | 1.8 (1.3–2.2) | 0.993 |
LDL (mmol/L) | 2.7 ± 0.8 | 3.0 ± 1.1 | 0.031 |
TC (mmol/L) | 4.5 ± 1.0 | 4.6 ± 1.1 | 0.181 |
Scr (μmol/L) | 67.0 (55.0–77.0) | 64.5 (55.0–78.0) | 0.647 |
BUN (mmol/L) | 5.4 (4.4–6.6) | 5.7 (4.6–7.4) | 0.166 |
UA (mmol/L) | 330.8 ± 88.4 | 313.4 ± 95.8 | 0.157 |
Infarct size (mm) | 13.4 ± 4.9 | 14.5 ± 5.0 | 0.112 |
BA stenosis, n (%) | 35 (19.7) | 20 (25.6) | 0.284 |